AVADEL PHARMACEUTICALS PLC 3 SEC Filings

Filed On	Filing
18 Feb 2026	Form 3: Weiss Asset Management Lp, 10% owner and 1 other Holds 11,112,052 shares of Ordinary Shares
13 May 2025	Form 3: Rodriguez Susan, Chief Operating Officer No securities owned
21 May 2024	Form 3: Amin Naseem, Director No securities owned
03 May 2024	Form 3: Seurer Jerad G., Gen. Counsel & Corp. Secretary Holds 8,795 shares of Ordinary Shares
16 Feb 2022	Form 3: Williamson Douglas J, Chief Medical Officer No securities owned
17 Feb 2021	Form 3: Kim Richard J, Chief Commercial Officer No securities owned
09 Dec 2019	Form 3: McCamish Mark Anthony, Director No securities owned
03 Dec 2019	Form 3: Mchugh Thomas S, Chief Financial Officer No securities owned
14 Nov 2019	Form 3: Vaughn Jason, Sr. VP, Technical Operations No securities owned
30 Apr 2019	Form 3: Dubow Jordan, Chief Medical Officer No securities owned
03 Jan 2019	Form 3: Ende Eric J, Director No securities owned
13 Dec 2018	Form 3: Kotler Kevin, Director and 2 others Holds 3,102,673 shares of ADSs
27 Jul 2018	Form 3: Palczuk Linda, Director No securities owned
27 Jul 2018	Form 3: Glass Geoffrey Michael, Director No securities owned
04 May 2018	Form 3: Flynn James E, 10% owner and 6 others Holds 1,066,299 shares of American Depositary Shares
29 Jun 2017	Form 3: Thornton Peter J., Director No securities owned
12 Jan 2017	Form 3: Divis Greg J, See Remarks
06 Jan 2017	Form 3: Broadfin Healthcare Master Fund Ltd, 10% owner and 2 others Holds 4,394,464 shares of Ordinary Shares
06 Jan 2017	Form 3: Broadfin Healthcare Master Fund Ltd, 10% owner and 2 others Holds 4,394,464 shares of Ordinary Shares
03 Jan 2017	Form 3: Sullivan Stephen G., VP, Strategic Marketing No securities owned

Comments